ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Committee Approves Concepts For Studies In Special Populations

December 11, 1987

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says

February 3, 1995

CCOP Pink Sheets Go Out, Details Starting to Emerge On Number Of Awards, Payline, Possible Exceptions

May 6, 1983

Lasker Official Urges Congressional Support Of NCI Bypass Budget

April 20, 1990

Conversation with Walter Curran – Proton Therapy: What’s Known and What’s Not

October 25, 2013